Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,418.13
-2.2947-0.09%
Number of Gainers:54
Number of Losers:42
Number of Flat:1
PE:- -
High:2,427.85
Open:2,420.66
Low:2,412.53
Close:2,420.42
Volume:1.20B
Turnover:254.68B
Market Cap:50.75T
Float Cap:47.32T

Loading ...

Why Moderna's mRNA Cancer Drug Hype Has Gone Too Far

Dow Jones
·
Aug 22

LIVE Markets-Nvidia to Put Finishing Touches on Banner US Earnings Season

Reuters
·
Aug 22

U.S. Stocks on the MOVE-Moderna, O-I Glass, Aveanna Healthcare

Reuters
·
Aug 22

Nevada approves Tesla fleet of 5,000 fully autonomous vehicles

TIPRANKS
·
Aug 22

UnitedHealth Group (UNH) Stock Looks Cheap On Value But Faces Risk On News

Simply Wall St.
·
Aug 22

Salesforce (CRM) Gets A New No Code Workflow Layer Inside Its CRM

Simply Wall St.
·
Aug 22

Cboe data shows mixed options sentiment in Apple with shareslittle changed

TIPRANKS
·
Aug 22

Tesla Stock's Jumps as the Company Gets Ready for a Robotaxi Push

Dow Jones
·
Aug 22

Microsoft Stock (NASDAQ:MSFT) Notches Up With 22 New Security Patches

TIPRANKS
·
Aug 22

Cboe data shows mixed options sentiment in Microsoft with shares up 0.55%

TIPRANKS
·
Aug 22

Eric Trump-Backed Space-Eyes to Appoint Ex-Delta Force Officer and Ex-Banker, Sources Say

Reuters
·
Aug 22

Tesla Shuts Down Solar Roof Operations, Tesla Stock (NASDAQ:TSLA) Surges

TIPRANKS
·
Aug 22

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

TIPRANKS
·
Aug 22

TG Therapeutics Advances Injectable MS Therapy With New Phase 2 Device Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Pfizer’s India Migraine Study Adds Real-World Momentum for PFE

TIPRANKS
·
Aug 22

Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story

TIPRANKS
·
Aug 22

Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

TIPRANKS
·
Aug 22